← Eichor
Condition: Optic Glioma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Optic Glioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Modified CV Regimen in Optic Pathway Glioma
Phase 2 · 1 location(s) · Beijing Sanbo Brain Hospital · NCT05278715Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgi
EARLY_Phase 1 · 1 location(s) · Eben Rosenthal · NCT07493447Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Phase 1/Phase 2 · 1 location(s) · Stanford University · NCT03510208Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
NA · 2 location(s) · St. Jude Children's Research Hospital · NCT04065776Loupe-Based Intraoperative Fluorescence Imaging
Phase N/A · 1 location(s) · Guoqiang Yu · NCT04780009Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Phase N/A · 3 location(s) · Maastricht Radiation Oncology · NCT04648462
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.